Robert A. Kyle, MD
Myeloma survivors owe much to Robert A. Kyle’s reluctance to perform autopsies or to undergo cardiac catheterization.
A Landmark Paper
When Kyle began to study dysproteinemia in 1960, routine blood tests frequently found monoclonal gammopathies in patients with no symptoms of MM or other disease.
A Treasure Trove of Data
When Kyle talks of going back to his records, he speaks of an incredible asset. Kyle’s longevity and work ethic, combined with some early success with data mining, led him to amass an unprecedented collection of patients with dysproteinemia and to invent breakthrough strategies for teasing insight from their files.
... to read the full story